SequelSEC

U S PHYSICAL THERAPY INC /NV USPH

Services-Health Services · CIK 0000885978 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$214.06M
Fiscal year ended 2026-06-30
Operating income
$21.95M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

U S PHYSICAL THERAPY INC /NV (USPH) reported revenue of $214.06M and net income of $9.90M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from U S PHYSICAL THERAPY INC /NV’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Health Services.

Income

U S PHYSICAL THERAPY INC /NV income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Revenue$214.06M$198.29M$202.73M$197.13M$197.34M$183.79M$180.45M$168.03M$167.19M$155.68M
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profit$41.94M$32.75M$40.13M$36.87M$41.62M$31.06M$32.53M$29.13M$33.86M$28.40M
Operating income$21.95M$12.48M$16.77M$25.33M$24.94M$19.64M$19.65M$12.85M$15.57M$14.93M
Net income$9.90M$5.04M$4.15M$13.14M$12.39M$9.90M$9.24M$6.63M$7.51M$8.05M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 15.07Mshares 15.17MUnavailableshares 15.20Mshares 15.20Mshares 15.13MUnavailableshares 15.08Mshares 15.07Mshares 15.02M
Pretax income$19.05M$10.56M$14.96M$22.88M$22.65M$17.33M$18.32M$12.34M$14.80M$14.76M
Income tax expense$4.16M$2.41M$5.78M$5.23M$4.93M$3.86M$5.83M$2.56M$3.08M$3.14M
Diluted EPS$0.25$-0.12Unavailable$0.48$0.58$0.80Unavailable$0.39$0.47$0.46
Selling, general & administrative$19.00M$18.27M$18.12M$17.41M$17.48M$16.24M$15.57M$14.38M$14.25M$14.08M
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

U S PHYSICAL THERAPY INC /NV balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalents$24.89M$28.44M$35.57M$31.10M$34.09M$39.18M$41.36M$116.96M$112.91M$132.29M
Total assets$1.25B$1.24B$1.20B$1.20B$1.18B$1.18B$1.17B$1.03B$1.02B$1.02B
Current assets$139.68M$139.11M$139.99M$138.44M$140.53M$145.35M$137.58M$204.87M$201.68M$221.14M
Total liabilities$482.22M$459.19M$433.81M$413.83M$414.01M$420.68M$408.42M$358.47M$353.16M$345.29M
Current liabilities$109.91M$117.30M$139.04M$115.08M$118.84M$123.80M$116.28M$115.30M$107.10M$102.54M
Total equity incl. NCI$449.17M$469.43M$476.89M$504.78M$502.29M$498.96M$490.02M$484.12M$485.62M$481.23M
Temporary (mezzanine) equity$317.49M$313.44M$293.31M$277.66M$263.30M$260.05M$269.02M$186.60M$184.35M$190.73M
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$69.60M$69.08M$64.25M$67.63M$65.96M$64.76M$59.04M$57.02M$54.66M$55.36M
Goodwill$716.54M$715.87M$692.39M$690.41M$677.60M$674.39M$667.15M$554.64M$548.97M$534.27M
Long-term debt$215.46M$194.04M$152.59M$151.46M$151.91M$157.24M$142.53M$132.92M$135.70M$136.75M
Accounts payableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

U S PHYSICAL THERAPY INC /NV cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow$34.37M$3.81M$24.93M$19.94M$34.86M-$4.68M$19.41M$22.12M$28.99M$4.42M
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flow-$6.41M-$39.80M-$5.44M-$11.94M-$12.71M-$6.63M-$94.85M-$5.84M-$28.29M-$20.46M
Financing cash flow-$31.52M$28.86M-$15.02M-$10.99M-$27.25M$9.12M-$153.00K-$12.23M-$20.08M-$4.49M
Net change in cash-$3.55M-$7.13M$4.47M-$2.98M-$5.10M-$2.18M-$75.60M$4.05M-$19.38M-$20.54M
Stock-based compensation$3.17M$2.31M$2.12M$2.26M$2.12M$1.77M$1.99M$1.92M$1.92M$2.00M
Common dividends paidUnavailableUnavailable$6.84M$6.84MUnavailableUnavailable$6.64M$6.63MUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$5.62M$6.00M$4.64M$5.50M$5.74M$5.87M$5.53M$4.16M$4.30M$4.10M

Derived

U S PHYSICAL THERAPY INC /NV derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross margin19.6%16.5%19.8%18.7%21.1%16.9%18.0%17.3%20.3%18.2%
Operating margin10.3%6.3%8.3%12.8%12.6%10.7%10.9%7.6%9.3%9.6%
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenue1.5%1.2%1.0%1.1%1.1%1.0%1.1%1.1%1.1%1.3%
Current ratio1.27x1.19x1.01x1.20x1.18x1.17x1.18x1.78x1.88x2.16x
Revenue YoY growth8.5%7.9%12.3%17.3%18.0%18.1%16.6%12.0%10.4%4.8%
Net margin4.6%2.5%2.0%6.7%6.3%5.4%5.1%3.9%4.5%5.2%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equity0.48xUnavailable0.32x0.30xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate21.8%22.8%38.7%22.9%21.8%22.3%31.8%20.7%20.8%21.3%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open USPH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-07View SEC filing
10-Q · Filed 2026-05-08View SEC filing
10-K · Filed 2026-02-27View SEC filing
10-Q · Filed 2025-11-07View SEC filing
10-Q · Filed 2025-08-08View SEC filing
10-Q · Filed 2025-05-09View SEC filing

Companies in the same industry

Reconciliation checks needing review

1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationreview2023-09-30

Difference 12948000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.